Nonindustry-Sponsored Preclinical Studies on Statins Yield Greater Efficacy Estimates Than Industry-Sponsored Studies: A Meta-Analysis

Open Access

Peer-reviewed

Research Article

David Krauth,

Affiliation Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, United States of America
⨯
Andrew Anglemyer,

Affiliation Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, United States of America
⨯
Rose Philipps,

Affiliation Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, United States of America
⨯
Lisa Bero

* E-mail: berol@pharmacy.ucsf.edu

Affiliations Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, United States of America, Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, United States of America
⨯

Reader Comments (0)

Statins
Is the Subject Area "Statins" applicable to this article?

Thanks for your feedback.
Finance
Is the Subject Area "Finance" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Animal studies
Is the Subject Area "Animal studies" applicable to this article?

Thanks for your feedback.
Atherosclerosis
Is the Subject Area "Atherosclerosis" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.